skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Sunday, June 7, 2020

COVID-19 - How To Protect Yourself And Others - CDC.gov

The pandemic is not over yet!


The CDC tells us:

How to Protect Yourself & Others



Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 5:57 AM
Labels: cdc, COVID, guidelines, recommendations

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course


SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2026 #2027 #2028

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2026

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2026 #2027 #2028

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Marler Blog
    Spruce Pine North Carolina hit again with Salmonella and Campylobacter and El Ranchero
    2 hours ago
  • All Kaiser Health News
    Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
    18 hours ago
  • Science-Based Medicine
    The Authors of the Book “The War on Science” Won Their War. Are They Happy Now?
    20 hours ago
  • CNBC Health Care
    AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
    1 day ago
  • Government Executive
    Lawmakers aim to force the Army to detail its transformation plans
    1 day ago
  • Medtech Insight
    Bipartisan Bills Seek ‘RESULTS’ On Medicare Rates For Clinical Diagnostic Labs
    1 day ago
  • GEN Biotech News
    How Germinal Centers Generate Antibodies Through Noisy Rounds of Mutation and Selection
    1 day ago
  • eLearning Industry
    Jotform Pricing Plans 2026: Which Plan Is Right For You?
    1 day ago
  • FiercePharma
    Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
    1 day ago
  • Medscape Today Headlines
    Microvascular Disease and MACE: Unmasking the High Risk
    1 day ago
  • BioPharma Dive - Latest News
    Study data convince Lundbeck to push new migraine drug forward
    1 day ago
  • FierceBiotech: Medtech
    Insulet debuts latest enhancements to popular Omnipod insulin delivery system
    1 day ago
  • BioPharma Dive
    Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
    1 day ago
  • Drug Channels
    Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
    1 day ago
  • Wellness Blog - NY Times
    Her Throat Was on Fire. What Was Wrong?
    1 day ago
  • Drug & Device Law
    Case Vetting Order in the Thalidomide Litigation
    1 day ago
  • Pharmafile
    Phase 2 study explores imaging approach for interstitial lung disease
    1 day ago
  • FDA What's New: Drugs
    Lipofit Extreme 2.0 Fat Burner may be harmful due to hidden drug ingredients
    2 days ago
  • JD Supra Law News
    Healthcare Authority Newsletter - May 2026 #4
    2 days ago
  • Pharmaceutical Commerce
    2 days ago
  • Food Poison Journal
    Ricotta Cheese recalled over Listeria
    3 days ago
  • The Compliance and Ethics Blog
    New sheriff in town? Examining state enforcement of AI laws
    3 days ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
    3 days ago
  • FierceBiotech
    Lilly, Boehringer to slash at least $1B each from planned investments in Germany
    3 days ago
  • Clinical Correlations
    The History of Pacemakers and Where They Are Heading
    4 days ago
  • FDA - Press Releases
    FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
    4 days ago
  • Clarkston Consulting
    Key Considerations for Creating a More Circular Retail Supply Chain
    4 days ago
  • Asbestos and Mesothelioma News
    Fungus-Derived Compounds Show Promise Against Mesothelioma
    1 week ago
  • Quality Matters
    Earlier scientific engagement is reshaping how pharmaceutical quality standards take shape
    1 week ago
  • The Incidental Economist
    Why Long-Term Care Policy Keeps Failing – and How to Fix It
    2 weeks ago
  • Pharmafile - Mfg & Production
    Vetter begins construction of new injectable medicines facility
    2 weeks ago
  • World Pharma - Breaking News
    AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
    4 weeks ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    1 month ago
  • Eye on FDA
    Is cooking with olive oil really beneficial for your health? Expert Answers
    2 months ago
  • Ted Eytan, MD
    San Juan, Puerto Rico
    3 months ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    4 months ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    6 months ago
  • 33 Charts
    The AI coding arms race
    7 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    10 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    1 year ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    1 year ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    1 year ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    1 year ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    1 year ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    1 year ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    2 years ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    2 years ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ▼  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ▼  June (2)
      • California Designated Representative Training Cour...
      • COVID-19 - How To Protect Yourself And Others - CD...
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo